188 related articles for article (PubMed ID: 23918244)
1. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.
Reddon H; Milloy MJ; Simo A; Montaner J; Wood E; Kerr T
AIDS Behav; 2014 Apr; 18(4):740-6. PubMed ID: 23918244
[TBL] [Abstract][Full Text] [Related]
2. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
[TBL] [Abstract][Full Text] [Related]
3. Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.
Socías ME; Wood E; McNeil R; Kerr T; Dong H; Shoveller J; Montaner J; Milloy MJ
Int J Drug Policy; 2017 Jul; 45():1-8. PubMed ID: 28454044
[TBL] [Abstract][Full Text] [Related]
4. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
Shrestha R; Copenhaver MM
Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
[TBL] [Abstract][Full Text] [Related]
6. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.
Bach P; Wood E; Dong H; Guillemi S; Kerr T; Montaner J; Milloy MJ
BMC Infect Dis; 2015 Nov; 15():537. PubMed ID: 26586238
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
[TBL] [Abstract][Full Text] [Related]
8. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
[TBL] [Abstract][Full Text] [Related]
9. Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study.
Sangsari S; Milloy MJ; Ibrahim A; Kerr T; Zhang R; Montaner J; Wood E
BMC Infect Dis; 2012 Jan; 12():22. PubMed ID: 22276960
[TBL] [Abstract][Full Text] [Related]
10. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting.
Werb D; Milloy MJ; Kerr T; Zhang R; Montaner J; Wood E
AIDS Behav; 2013 Jan; 17(1):68-73. PubMed ID: 22249956
[TBL] [Abstract][Full Text] [Related]
11. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
[TBL] [Abstract][Full Text] [Related]
12. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.
Ti L; Milloy MJ; Shannon K; Simo A; Hogg RS; Guillemi S; Montaner J; Kerr T; Wood E
Sex Transm Infect; 2014 Aug; 90(5):418-22. PubMed ID: 24523347
[TBL] [Abstract][Full Text] [Related]
14. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
[TBL] [Abstract][Full Text] [Related]
16. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
19. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
Milloy MJ; Kerr T; Buxton J; Rhodes T; Krusi A; Guillemi S; Hogg R; Montaner J; Wood E
J Acquir Immune Defic Syndr; 2012 Apr; 59(4):393-9. PubMed ID: 22134149
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada.
Klimas J; Nosova E; Socías E; Nolan S; Brar R; Hayashi K; Milloy MJ; Kerr T; Wood E
Drug Alcohol Depend; 2018 May; 186():182-186. PubMed ID: 29604525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
